Kelly Michael Gerald

Avg. Two Year Performance

No purchase track record

79% Avg. Sale Return

34% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	< 1%	(5%)	14%	71%	79%
Sale Success Rate	3 of 8	4 of 8	6 of 8	8 of 8	7 of 8

Renovis Inc

Drugs » Biotechnology

SVP, Research & Development:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--